Correlation Between Meinian Onehealth and Jinhe Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Meinian Onehealth and Jinhe Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Meinian Onehealth and Jinhe Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Meinian Onehealth Healthcare and Jinhe Biotechnology Co, you can compare the effects of market volatilities on Meinian Onehealth and Jinhe Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Meinian Onehealth with a short position of Jinhe Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Meinian Onehealth and Jinhe Biotechnology.

Diversification Opportunities for Meinian Onehealth and Jinhe Biotechnology

0.91
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Meinian and Jinhe is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding Meinian Onehealth Healthcare and Jinhe Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jinhe Biotechnology and Meinian Onehealth is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Meinian Onehealth Healthcare are associated (or correlated) with Jinhe Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jinhe Biotechnology has no effect on the direction of Meinian Onehealth i.e., Meinian Onehealth and Jinhe Biotechnology go up and down completely randomly.

Pair Corralation between Meinian Onehealth and Jinhe Biotechnology

Assuming the 90 days trading horizon Meinian Onehealth Healthcare is expected to generate 1.47 times more return on investment than Jinhe Biotechnology. However, Meinian Onehealth is 1.47 times more volatile than Jinhe Biotechnology Co. It trades about 0.11 of its potential returns per unit of risk. Jinhe Biotechnology Co is currently generating about 0.09 per unit of risk. If you would invest  433.00  in Meinian Onehealth Healthcare on August 30, 2024 and sell it today you would earn a total of  55.00  from holding Meinian Onehealth Healthcare or generate 12.7% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Meinian Onehealth Healthcare  vs.  Jinhe Biotechnology Co

 Performance 
       Timeline  
Meinian Onehealth 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Meinian Onehealth Healthcare are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Meinian Onehealth sustained solid returns over the last few months and may actually be approaching a breakup point.
Jinhe Biotechnology 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Jinhe Biotechnology Co are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Jinhe Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point.

Meinian Onehealth and Jinhe Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Meinian Onehealth and Jinhe Biotechnology

The main advantage of trading using opposite Meinian Onehealth and Jinhe Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Meinian Onehealth position performs unexpectedly, Jinhe Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jinhe Biotechnology will offset losses from the drop in Jinhe Biotechnology's long position.
The idea behind Meinian Onehealth Healthcare and Jinhe Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
CEOs Directory
Screen CEOs from public companies around the world
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance